Tolerance of postoperative chemotherapy involving taxol and cisplatin in ovarian cancer patients
Standard management of ovarian cancer includes cytoreductive surgery and subsequent adjuvant chemotherapy. The purpose of this study was an evaluation of the treatment process and toxicity of taxol and cisplatin in a standard medical procedure for women who underwent a surgery due to ovarian cancer. Participants of our study were 30 women, operated in our department due to ovarian carcinoma. The tolerance of chemotherapy was assessed according to WHO toxicity scale. The answer to the treatment in terms of remission was observed in 80% patients. The results of our study are able to have an important clinical value for future chemotherapy treatment.